ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,885, issued on July 14, was assigned to SHANGHAITECH UNIVERSITY (Shanghai).
"Composition and methods to treat ectodermal dysplasia 2, Clouston type" was invented by Fabio Mammano (Padua, Italy), Guang Yang (Shanghai) and Francesco Zonta (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates generally to compositions and methods of preventing or treating diseases associated with mutant Cx26, Cx32, and/or Cx30hemichannels. The present technology also relates to administering the anti-Cx26 hemichannel antibodies in effective amounts to treat a subject suffering from, or predisposed to, ectodermal dysplasia 2, Clouston t...